These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2395285)

  • 1. [Nonspecific immunotherapy with BCG vaccine in bladder tumors].
    Damianov Kh; Patrashkov T; Petkov Ts; Tonchev T; Petrov P
    Khirurgiia (Sofiia); 1990; 43(1):48-53. PubMed ID: 2395285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of BCG vaccine in the treatment of surface tumors of the bladder].
    Kumanov Kh; Ormanov I; Engibarov A
    Urol Nefrol (Mosk); 1989; (5):41-4. PubMed ID: 2595863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer.
    Hilton WM; Ercole B; Parekh DJ; Sonpavde G; Ghosh R; Svatek RS
    Expert Rev Anticancer Ther; 2011 Jun; 11(6):949-57. PubMed ID: 21707292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunochemotherapy of advanced bladder tumors].
    Damionov C; Petkov T
    J Urol (Paris); 1989; 95(7):406-11. PubMed ID: 2687394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG vaccine therapy for treatment of superficial bladder cancer.
    Damianov C; Patrashkov T; Tonchev T; Engibarov A; Kasabov V; Chouchkova M
    Int Urol Nephrol; 1989; 21(3):305-12. PubMed ID: 2807782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative clinical trial of UFT medication and intravesical BCG in the recurrence of superficial bladder cancer. Study Group of UFT and BCG adjuvant therapy for bladder cancer].
    Oda H; Seki N; Nabeshima S; Oda T; Nishio S; Yokoyama M; Iwata H; Takeuchi M; Matsumoto A; Terado T
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2051-5. PubMed ID: 2221929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined immunochemotherapy (CEP, M-VEP + BCG) in the treatment of invasive bladder tumors.
    Damianov C; Terziev T; Koleva P; Chuchkova M
    Anticancer Drugs; 1994 Jun; 5(3):298-304. PubMed ID: 7919454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
    van der Meijden AP
    Prog Clin Biol Res; 1992; 378():95-101. PubMed ID: 1301591
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intravesical BCG therapy in patients with recurrent superficial bladder tumors].
    Sugimoto M; Yamamoto H; Itakura H; Shinohara M; Kinoshita K
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3725-8. PubMed ID: 2596855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical therapy for bladder cancer.
    Williams SK; Hoenig DM; Ghavamian R; Soloway M
    Expert Opin Pharmacother; 2010 Apr; 11(6):947-58. PubMed ID: 20205607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer.
    Chen CH; Yang HJ; Shun CT; Huang CY; Huang KH; Yu HJ; Pu YS
    Urol Oncol; 2012; 30(4):421-7. PubMed ID: 20870427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravesical bacillus Calmette-Guerin therapy for superficial bladder tumor: experience of 13 cases].
    Okuno H; Shirahase T; Kihara Y; Arai Y
    Hinyokika Kiyo; 1989 Sep; 35(9):1503-7. PubMed ID: 2816616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of superficial bladder tumors with intravesical BCG vaccine].
    Damianov Kh; Engibarov A; Patrashkov T; Tonchev T; Chuchkova M
    Khirurgiia (Sofiia); 1988; 41(2):23-8. PubMed ID: 3411877
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
    Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M
    J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravesical BCG therapy for superficial bladder cancer].
    Segawa N; Iwamoto Y; Azuma H; Yamamoto K; Ueda H; Katsuoka Y
    Hinyokika Kiyo; 1998 Sep; 44(9):627-31. PubMed ID: 9805666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCG.
    Sanchez-Carbayo M; Urrutia M; Romani R; Herrero M; Gonzalez de Buitrago JM; Navajo JA
    Anticancer Res; 2001; 21(4B):3041-7. PubMed ID: 11712808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Our experience in treating patients with surface cancer of the bladder].
    Matveev BP; Figurin KM; Romanov VA; Cheban NL
    Urol Nefrol (Mosk); 1995; (5):35-8. PubMed ID: 8571484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results obtained by intravesical instillation of BCG in superficial bladder tumors].
    Romics I; Dietmar B; Christoph R
    Orv Hetil; 1990 Jan; 131(1):25-8. PubMed ID: 2405331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [BCG immunotherapy in the treatment of superficial bladder tumors].
    Samodai L; Drinóczy M; Kolozsy Z; Mohácsi L; Dauda G; Porkoláb Z
    Orv Hetil; 1986 Oct; 127(40):2441-6. PubMed ID: 3537907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.